List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 608 studies with search of: Interferon alfa-2 OR "Roferon-A (2a) OR Intron A (2b)"[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Decitabine;   Drug: Interferon Alfa-2b
2 Recruiting Zidovudine, Interferon Alfa-2b, and PEG-Interferon Alfa-2b in Treating Patients With Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia/Lymphoma
Conditions: Lymphoma;   Precancerous/Nonmalignant Condition
Interventions: Biological: PEG-interferon alfa-2b;   Biological: recombinant interferon alfa-2b;   Drug: valproic acid;   Drug: zidovudine;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis
3 Recruiting Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Dialysis Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Pegylated interferon alfa-2a plus low dose ribavirin;   Drug: Pegylated interferon alfa
4 Completed
Has Results 		Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin
Conditions: Chronic Hepatitis C;   Hemodialysis
Intervention: Drug: Pegylated interferon alfa-2a and ribavirin
5 Terminated Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders
Condition: Hepatitis C, Chronic
Interventions: Drug: peg-interferon alfa-2b;   Drug: ribavirin;   Drug: amantadine
6 Completed A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
Condition: HIV Infections
Interventions: Drug: Interferon alfa-2a;   Drug: Zidovudine;   Drug: Zalcitabine
7 Active, not recruiting Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
Condition: Non-Melanomatous Skin Cancer
Interventions: Biological: PEG-interferon alfa-2a;   Drug: gefitinib
8 Active, not recruiting Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies
Conditions: Advanced Malignancies;   Solid Tumors
Interventions: Drug: Sodium Stibogluconate;   Drug: Interferon Alpha-2b
9 Recruiting Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D
Intervention: Drug: pegylated IFN alfa-2b plus ribavirin
10 Recruiting Interferon Alfa-2b in Treating Patients Who Have Undergone Surgery for High-Risk or Metastatic Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: recombinant interferon alfa-2b;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: flow cytometry;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy
11 Recruiting Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: PEG-interferon alfa-2b;   Drug: decitabine
12 Not yet recruiting Sodium Stibogluconate and Interferon Alfa-2b Followed By Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Advanced Melanoma or Other Cancer
Conditions: Brain and Central Nervous System Tumors;   Melanoma (Skin)
Interventions: Biological: recombinant interferon alfa-2b;   Drug: cisplatin;   Drug: sodium stibogluconate;   Drug: temozolomide;   Drug: vinblastine;   Genetic: gene expression analysis;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: pharmacological study
13 Not yet recruiting Study Comparing Reduction and Viral Safety of IFN Alfa-2b XL + Ribavirin Versus PEG IFN Alfa-2b + Ribavirin in Patients With Chronic Hepatitis C Genotype 1
Condition: Chronic Hepatitis C
Interventions: Drug: IFN alfa-2b XL 27 MUI + Ribavirin;   Drug: IFN alfa-2b XL 36 MUI + Ribavirin;   Drug: IFN peg alfa-2b 1.5 µg/kg + Ribavirin
14 Recruiting Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm
Condition: Advanced Neoplasm
Intervention: Drug: Vinorelbine, Cyclophosphamide and Interferon alpha 2b
15 Completed Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Peg-interferon alpha 2a (drug);   Drug: Ribavirin (drug);   Drug: Interferon gamma (drug)
16 Completed Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients
Conditions: HIV Infections;   Chronic Hepatitis C
Interventions: Drug: Interleukin 2;   Drug: pegylated interferon alpha 2a;   Drug: ribavirin
17 Recruiting Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a
Conditions: Birdshot Retine Choroidopathy;   Cystoid Macular Edema;   Visual Acuity Loss
Interventions: Drug: interferon alpha 2a;   Drug: prednisone
18 Completed The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Interferon alfa-2b;   Drug: Zidovudine;   Drug: Zalcitabine;   Drug: Didanosine
19 Recruiting Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Pegylated interferon alfa-2a
20 Active, not recruiting Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: PEG-interferon alfa-2b;   Drug: temozolomide

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services